Drugs / YF vaccine (live)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07002060 Comparator | May 2025 → Jan 2026 | yellow fever | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YF vaccine (live) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07002060 ↗ |
| Modality | Vaccine | “YF-VAX (YF licensed vaccine)” NCT07002060 ↗ |
| Route | Subcutaneous | “will be administered subcutaneously” NCT07002060 ↗ |